Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03502785
Recruitment Status : Active, not recruiting
First Posted : April 19, 2018
Last Update Posted : October 2, 2019
Sponsor:
Information provided by (Responsible Party):
Inovio Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : March 2020
Estimated Study Completion Date : September 2020